Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
The KRAS oncogene product is considered a major target in anticancer drug discovery 1, 2,
3. However, direct interference with KRAS signalling has not yet led to clinically useful drugs
3, 4, 5, 6, 7, 8. Correct localization and signalling by farnesylated KRAS is regulated by the …
3. However, direct interference with KRAS signalling has not yet led to clinically useful drugs
3, 4, 5, 6, 7, 8. Correct localization and signalling by farnesylated KRAS is regulated by the …
Small-molecule modulation of Ras signaling
J Spiegel, PM Cromm, G Zimmermann… - Nature chemical …, 2014 - nature.com
Despite intense efforts in pharmaceutical industry and academia, a therapeutic grip on
oncogenic Ras proteins has remained elusive. Mutated Ras is associated with∼ 20− 30% of
all human cancers often not responsive to established therapies. In particular, K-Ras, the …
oncogenic Ras proteins has remained elusive. Mutated Ras is associated with∼ 20− 30% of
all human cancers often not responsive to established therapies. In particular, K-Ras, the …
Dissociation of the K-Ras4B/PDEδ complex upon contact with lipid membranes: membrane delivery instead of extraction
…, S Möbitz, G Zimmermann… - Journal of the …, 2012 - ACS Publications
K-Ras4B is a small GTPase whose selective membrane localization and clustering into
microdomains are mediated by its polybasic farnesylated C-terminus. The importance of the
subcellular distribution for the signaling activity of K-Ras4B became apparent from recent in …
microdomains are mediated by its polybasic farnesylated C-terminus. The importance of the
subcellular distribution for the signaling activity of K-Ras4B became apparent from recent in …
[HTML][HTML] Identification of pyrazolopyridazinones as PDEδ inhibitors
…, EK Fansa, S Ismail, G Zimmermann… - Nature …, 2016 - nature.com
The prenyl-binding protein PDEδ is crucial for the plasma membrane localization of
prenylated Ras. Recently, we have reported that the small-molecule Deltarasin binds to the
prenyl-binding pocket of PDEδ, and impairs Ras enrichment at the plasma membrane …
prenylated Ras. Recently, we have reported that the small-molecule Deltarasin binds to the
prenyl-binding pocket of PDEδ, and impairs Ras enrichment at the plasma membrane …
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site
G Zimmermann, C Schultz-Fademrecht… - Journal of medicinal …, 2014 - ACS Publications
K-Ras is one of the most frequently mutated signal transducing human oncogenes. Ras
signaling activity requires correct cellular localization of the GTPase. The spatial
organization of K-Ras is controlled by the prenyl binding protein PDEδ, which enhances Ras …
signaling activity requires correct cellular localization of the GTPase. The spatial
organization of K-Ras is controlled by the prenyl binding protein PDEδ, which enhances Ras …
DNA-encoded chemical libraries: foundations and applications in lead discovery
G Zimmermann, D Neri - Drug discovery today, 2016 - Elsevier
DNA-encoded chemical libraries have emerged as a powerful tool for hit identification in the
pharmaceutical industry and in academia. Similar to biological display techniques (such as
phage display technology), DNA-encoded chemical libraries contain a link between the …
pharmaceutical industry and in academia. Similar to biological display techniques (such as
phage display technology), DNA-encoded chemical libraries contain a link between the …
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical …
…, G Verbruggen, I Zimmermann-Gorska… - Annals of the …, 2005 - ard.bmj.com
Objective: To develop evidence based recommendations for the management of hip
osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised
18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 …
osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised
18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 …
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including …
…, G Weseloh, I Zimmermann-Gorska - Annals of the …, 2000 - ard.bmj.com
BACKGROUND Osteoarthritis (OA) is the most common joint disease encountered
throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in
1998 to determine the methodological and logistical approach required for the development …
throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in
1998 to determine the methodological and logistical approach required for the development …
The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length
CH Riedel, P Zimmermann, U Jensen-Kondering… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—We hypothesize that in acute middle cerebral artery stroke,
thrombus lengths measured in thin-slice nonenhanced CT images define a limit beyond
which systemic thrombolysis will fail to recanalize occluded arteries. Methods—In 138 …
thrombus lengths measured in thin-slice nonenhanced CT images define a limit beyond
which systemic thrombolysis will fail to recanalize occluded arteries. Methods—In 138 …
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report
…, M Tiemann, R Parwaresch, M Zimmermann… - Blood, 2000 - Am Soc Hematology
The purpose of our study was to investigate the efficacy of an acute lymphoblastic leukemia
(ALL)-type treatment with moderate-dose, prophylactic cranial irradiation and without local
radiotherapy for childhood T-cell lymphoblastic lymphoma (T-LBL). From April 1990 to …
(ALL)-type treatment with moderate-dose, prophylactic cranial irradiation and without local
radiotherapy for childhood T-cell lymphoblastic lymphoma (T-LBL). From April 1990 to …